Dr. James Timourian reports

INNOVOTECH APPOINTS DR. CRAIG MILNE AS CHIEF EXECUTIVE OFFICER

Innovotech Inc. has appointed Dr. Craig Milne as chief executive officer (CEO) effective Aug. 1, 2023. Dr. Milne first joined Innovotech as a board member in July, 2019, and has served on the executive committee, audit committee and as chief business development officer. "Dr. Milne brings to IOT enthusiasm, energy, vision and more than a decade of leadership experience in rapidly growing technology companies," said Dr. James Timourian, present CEO and board chair. Dr. Milne has a PhD in immunology from the University of Toronto and an MBA in finance from the University of Alberta.

"I'm excited about the opportunity we have in front of us. Innovotech is recognized by leading medical device companies as their trusted partner in microbiology products and services. That is a strong base from where we can continue to add value to our business and the industry," said Dr. Milne.

In his previous role as CEO of Copperstone Technologies, an Edmonton-based robotics company, he led the acquisition of several global mining companies as key clients. He has worked with companies across a number of industry verticals, developing and executing effective strategies for sales, partnership development and finance. Dr. Milne will be granted 500,000 incentive stock options vesting over a four-year period at today's closing price of 10 cents and expiring in five years.

Dr. Timourian will resign from the CEO position at the end of July and continue supporting the company in his capacity as director and board chair.

About Innovotech Inc.

Innovotech is a Canadian biotechnology company owning proprietary intellectual property, conducting contract research, and owning and providing proprietary devices for testing in multiple applications in microbiology and can be found on-line.

We seek Safe Harbor.